Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response

Area of Science:

• Immunology
• Cellular Signaling

Background:

• Thy-1 (CD90) is a GPI-anchored protein on T cells with signaling capabilities.
• Antibody-mediated Thy-1 crosslinking mimics T cell receptor (TcR) signaling, driving T cell proliferation and differentiation.

Purpose of the Study:

• To investigate Thy-1 signaling's impact on T helper (Th) cell cytokine production (IFNγ, IL-4, IL-17A).
• To examine Thy-1's role in polarizing CD4+ T cells into Th1, Th2, and Th17 subsets.
• To compare Thy-1 signaling outcomes with TcR signaling.

Main Methods:

• Studied Thy-1 and TcR signaling in purified mouse CD4+ and CD8+ T cells.
• Analyzed cytokine production (IFNγ, IL-4, IL-17A) and transcription factor RORγt expression.
• Investigated other GPI-APs (Ly6A/E) for comparison.

Main Results:

• Thy-1 signaling, unlike TcR signaling, preferentially induced IL-17A and the Th17 transcription factor RORγt.
• Both CD4+ and CD8+ T cells responded to Thy-1 stimulation.
• Thy-1 stimulation promoted Th1, Th2, and Th17 polarization, with a notable increase in IL-4 and IL-17A production.

Conclusions:

• Thy-1 signaling offers a distinct pathway from TcR signaling, favoring Th17 responses.
• This Thy-1-driven Th17 bias may enhance defense against extracellular pathogens.
• Not all GPI-APs mediate TcR-like signaling for cytokine production.